Results 171 to 180 of about 53,473 (288)
The role and treatment of Helicobacter pylori infection in peptic ulcer disease: a review of the relationship between Helicobacter pylori infection and peptic ulcer disease [PDF]
P. Fletcher, Duncan Q.M. Craig
openalex +1 more source
Deficiency of Aging‐Related Gene Chitinase‐Like 4 Impairs Olfactory Epithelium Homeostasis
Deficiency of Chil4 impairs OE homeostasis through loss of sustentacular cells and a specific type of immature sensory neuron, cell cycle arrest in globose basal cells, and inflammatory activation in microglia‐like cells. ABSTRACT Mammalian olfactory epithelium (OE) undergoes consistent self‐renewal throughout life.
Tingting Wu+7 more
wiley +1 more source
Oral malodor in Special Care Patients: current knowledge [PDF]
Epidemiological studies report that about 50% of the population may have oral malodor with a strong social and psychological impact in their daily life.
G., Allocca+6 more
core
Objectives Conventional nodular gastritis has been known to be caused by Helicobacter pylori infection. Several cases of gastric mucosa‐associated lymphoid tissue (MALT) lymphoma with non‐H. pylori Helicobacters (NHPH) exhibit endoscopic findings resembling nodular gastritis.
Yuki Kitadai+12 more
wiley +1 more source
Helicobacter pylori infection in Meckel's diverticula. [PDF]
K. M. Newbold, H J O’Connor
openalex +1 more source
Abstract Background The role of the gastric microbiome in the pathophysiology of gastritis beyond Helicobacter pylori (HP) infection is poorly understood and has remained unexplored in patients with obesity. The aim of this study was to analyse gastric mucosa‐associated microbiota in patients with obesity and nonatrophic chronic gastritis in the ...
José Ignacio Martínez‐Montoro+7 more
wiley +1 more source
ABSTRACT Background Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder frequently associated with immune‐mediated comorbidities, including inflammatory bowel disease (IBD). Given the potential risk of IBD, particularly before initiating therapies such as interleukin (IL)‐17 inhibitors, screening through a fecal calprotectin (FC) test
Neslihan Demirel Öğüt+7 more
wiley +1 more source